Property:Outcome timeline
This is a property of type Text.
B
Brown et al. (2019): Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Body Composition among Patients with Advanced or Metastatic Colorectal Cancer: A Randomized Trial +
T0: basline
T1: after cycle 4 of chemotherapy (8 weeks)
T2: after cycle 8 of chemotherapy (16 weeks)
Follow-Up +
Büntzel et al. (2010): Limited effects of selenium in the prevention of radiation-associated toxicities - results of a randomized study in head neck cancer patients +
Selenium concentration measured at baseline, after 4 weeks, after the end of Radiotherapy and 6 weeks after the end of Radiotherapy
Outcome assessed at baseline and then once a week and 6 weeks after Radiotherapy +
Büntzel et al. (2010): Selenium Substitution During Radiotherapy of Solid Tumours - Laboratory Data from Two Observation Studies in Gynaecological and Head and Neck Cancer Patients +
Selenium concentration measured at baseline, after 4 weeks, after the end of radiotherapy and 6 weeks after the end of radiotherapy
Overall duration: 7 weeks of radiotherapy +
C
Campos et al. (2011): Guarana (Paullinia cupana) Improves Fatigue in Breast Cancer Patients Undergoing Systemic Chemotherapy +
T0 = Baseline
T1 = Day 21 (after phase 1)
T2 = Day 49 (after phase 2) +
Cavallini et al. (2005): Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy +
T0: prior to therapy
T1: 4 month of therapy +
Chan et al. (2011): Nutritional supplements, COX-2 and IGF-1 expression in men on active surveillance for prostate cancer +
T0: Baseline
T1: after 12 weeks +
Chung et al. (2016): Randomized Trial of Vitamin C/E Complex for Prevention of Radiation- Induced Xerostomia in Patients with Head and Neck Cancer +
T0: before radiotherapy,
T1: 1 month post-radiotherapy,
T2: 6 months post-radiotherapy +
Cohen et al. (2018): Favorable Effects of a Ketogenic Diet on Physical Function, Perceived Energy, and Food Cravings in Women with Ovarian or Endometrial Cancer: A Randomized, Controlled Trial +
T0: Baseline
T1: after 12 weeks +
Crew et al. (2012): Phase IB Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Women with Hormone Receptor–Negative Breast Cancer +
T0 = Baseline
T1 = after 6 month +
Cruciani et al. (2009): L-Carnitine Supplementation in Patients with Advanced Cancer and Carnitine Deficiency: A Double-Blind, Placebo-Controlled Study +
T0: before intervention (baseline)
T1: 2 weeks (end of phase 1)
T2: 1 week after the start of the intervention
T3: 4 weeks (end of phase 2) +
Cruciani et al. (2012): L-Carnitine Supplementation for the Management of Fatigue in Patients With Cancer: An Eastern Cooperative Oncology Group Phase III, Randomized, Double-Blind, Placebo-Controlled Trial +
T0: Baseline
T1: after 4 weeks (first phase)
T2: after 8 weeks (second phase) +
Côté et al. (2016): Improving Quality of Life With Nabilone During Radiotherapy Treatments for Head and Neck Cancers: A Randomized Double-Blind Placebo-Controlled Trial +
T0: baseline before radiotherapy
T1: first week
T2: second week until
T3: 7<sup>th</sup> week
Follow-up: between 9<sup>th</sup> - 11<sup>th</sup> week +
D
Da Costa et al. (2009): Effectiveness of Guarana (Paullinia cupana) for Postradiation Fatigue and Depression Results of a Pilot Double-Blind Randomized Study +
T0: Day 0, immediately before the first radiation treatment
T1: Day 14, switching phase
T2: Day 28, right before the start of the last radiation treatment +
Dale et al. (2001): Co-medication with hydrolytic enzymes in radiation therapy of uterine cervix: evidence of the reduction of acute side effects +
T0: Baseline
T1: weekly for 5 weeks
Follow-up: after 6 weeks and 5 month after intervention +
Dardano et al. (2012): The effect of Ginkgo biloba extract on genotoxic damage in patients with differentiated thyroid carcinoma receiving thyroid remnant ablation with Iodine-131 +
Blood samples were drawn just before and at various intervals after <sup>131</sup>I therapy (at baseline and at 7, 17, 28, and 90 days). +
Del Giglio (2013): Purified Dry Extract of Paullinia cupana (Guarana) (PC-18) for Chemotherapy-Related Fatigue in Patients with Solid Tumors: An Early Discontinuation Study +
T0: Baseline, chemotherapy
T1: After 3 weeks (after induction)
T2: After 6 weeks (maintenance phase) +
Delanian et al. (2003): Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis +
T0: before randomization
T1: after 3 months
T2: after 6 months +
Dias et al. (2015): The chemopreventive effect of Ginkgo biloba extract 761 against cisplatin ototoxicity: a pilot study +
NI +
Dos Santos Martins (2016): Placebo-Controlled, Double-Blind, Randomized Study of a Dry Guarana Extract in Patients with Head and Neck Tumors Undergoing Chemoradiotherapy: Effects on Fatigue and Quality of Life +
T0: Baseline
T1: After 3 weeks
T2: After 6 weeks
T3: After 9 weeks +
Dyer et al. (2013): Is reflexology as effective as aromatherapy massage for symptom relief in an adult outpatient oncology population? +
T0: 1st intervention
T1: 2nd intervention
T2: 3rd intervention
T3: 4th intervention +